Low
₹16,176.40
High
₹16,334.69
Low
₹14,130.50
High
₹16,692.37
| Previous Close | ₹16,197.10 |
|---|---|
| Day's Range | ₹16,176.40 - ₹16,334.69 |
| Open | ₹16,334.04 |
| 52 Week Range | ₹14,130.50 - ₹16,692.37 |
| Volume | 9,99,31,606 |
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Blue Star Ltd. | 1656.00 | |
Consumer Durables |
| Exide Industries Ltd. | 349.00 | |
Automobile & Ancillaries |
| CRISIL Ltd. | 4135.70 | |
Ratings |
| CG Power and Industrial Solutions Ltd. | 837.90 | |
Capital Goods |
| Dabur India Ltd. | 469.50 | |
FMCG |
| Bharat Heavy Electricals Ltd. | 398.20 | |
Capital Goods |
| Hindustan Petroleum Corporation Ltd. | 366.20 | |
Crude Oil |
| Steel Authority Of India Ltd. | 192.35 | |
Iron & Steel |
| Godfrey Phillips India Ltd. | 2422.50 | |
FMCG |
| Godrej Industries Ltd. | 1132.05 | |
Chemicals |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 23643.5 | 26373.20 | 22182.55 |
| Nifty IT | 27716.9 | 40301.40 | 27078.00 |
| Nifty Next 50 | 69280.25 | 72037.60 | 59896.10 |
| NIFTY50 USD Index | 8543.55 | 10443.40 | 8132.40 |
| Nifty Bank | 53710.35 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 60567.15 | 62113.85 | 52032.85 |
| Nifty 500 | 22531.15 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 17273.15 | 17686.30 | 14804.55 |
| Nifty 100 | 24572.15 | 26975.15 | 22720.45 |
| Nifty FMCG | 51051.35 | 58485.05 | 45334.15 |
Cochin Shipyard has informed that it enclosed copies of the newspaper advertisements published regarding audited standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Muthoot Finance has informed that it enclosed a copy of the Newspaper Advertisements published on May 16, 2026, in Business Line (All India edition) and Metro Vaartha (All Kerala edition) in respect of the audited Financial Results for the Quarter and Year ended March 31, 2026.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, Gland Pharma has informed that it enclosed copies of the newspaper advertisement pertaining to Audited Financial Results of the Company for the financial year ended March 31, 2026. The advertisements were published in English and Telugu newspapers.
The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed that: CuraTeQ Biologics, a wholly owned subsidiary of Aurobindo Pharma, announced that the Central Drugs Standard Control Organization (CDSCO) has granted Marketing Authorisation under Form CT 23 for Bevqolva®, a bevacizumab biosimilar indicated for metastatic carcinoma of the colon or rectum. The authorisation permits manufacture at CuraTeQ’s facility in Hyderabad and marketing of Bevqolva® in 100 mg/4mL and 400 mg/16 mL vial presentations.
The above information is a part of company’s filings submitted to BSE.
Uno Minda has informed that the Nomination & Remuneration Committee of the Board of the Company at its meeting held on, on May 16, 2026, had approved the allotment of 34,990 equity shares of the face value of Rs. 2/- each, pursuant to the exercise of Options by the grantees under Uno Minda Employees Stock Option Scheme, 2019. The Company is in the process of applying for the listing of these shares with the stock exchanges i.e., NSE and BSE. The paid-up equity share capital of the Company stands increased from Rs. 1,15,48,43,632/- to Rs. 1,15,49,13,612/- In terms of Regulations l0(c) of the SEBI (Share Based Employee Benefits& Sweat Equity) Regulations, 2021 (‘SEBI Regulations’), the details of the share allotted as above are given in the Annexure-1 to this intimation. Further, this intimation is in terms of Regulation 30 of the SEBI (LODR) Regulations, 2015, however, the company has informed that the aforesaid allotment of shares is not material in nature to the Company. The aforesaid disclosures are also being made available on the website of the Company at www.unominda.com. The Meeting commenced at 09:30 am and concluded at 09:40 am.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The previous close of MID150 index is ₹16197.1 as of 2026-05-15.
The total volume of MID150 index is 99931606.00 as of 2026-05-15.
The percentage change in value of MID150 index is -0.48% as of 2026-05-15.
The absolute increase in MID150 index value since the previous trading day is ₹-77.67 as of 2026-05-15.
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.